MedPath

GSK-2018682

Generic Name
GSK-2018682
Drug Type
Small Molecule
Chemical Formula
C22H21ClN4O4
CAS Number
1034688-30-6
Unique Ingredient Identifier
NJL503AIJA

Overview

GSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.

Background

GSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath